Arpalit Neo, 4,7/1,2mg/g, Kožní sprej, roztok
Arpalit Neo, 4,7/1,2mg/g, Kožní sprej, roztok
Authorised
- Fenoxycarb
- Permethrin
Product identification
Medicine name:
Arpalit Neo, 4,7/1,2mg/g, Kožní sprej, roztok
Active substance:
- Fenoxycarb
- Permethrin
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Fenoxycarb1.20milligram(s)1.00gram(s)
-
Permethrin4.70milligram(s)1.00gram(s)
Pharmaceutical form:
-
Cutaneous spray, solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Aveflor a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Aveflor a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 99/033/09-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 4/09/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 4/09/2023
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 4/09/2023
How useful was this page?: